执掌经营仅3个月！000788，董事长突遭刑拘

Core Points - The chairman and president of Beijing University Pharmaceutical, Xu Xiren, has been criminally detained and is currently cooperating with investigations, temporarily unable to perform his duties [1][2] - The company has stated that its control has not changed, and the board of directors is operating normally, with financial and operational management remaining stable [2] - Xu Xiren remains the actual controller of the company, having authorized other executives to perform his duties during his absence [2] Company Background - Xu Xiren has been in control of Beijing University Pharmaceutical for only three months, having acquired control through a transaction involving the purchase of 100% of Southwest Synthetic Pharmaceutical Group [3] - The company has a long history, originally established in 1965, and has undergone several ownership changes, including being part of the Ping An Group and later transitioning to Xu Xiren's control in late 2024 [4] - The company reported a revenue of 957 million yuan for the first half of 2025, a decrease of 5.04% year-on-year, while net profit increased by 15.51% to 100 million yuan [4] Market Performance - As of October 29, the stock price of Beijing University Pharmaceutical closed at 6.17 yuan per share, with a total market capitalization of 3.677 billion yuan [5]